Blenrep

Events

Partner Content

BCMA Targeted Therapies Summit

Built with thought leaders from Seattle Genetics, Precision Biosciences and Kite Pharma, the inaugural industry-focused

News

GSK moves further ahead in BCMA with EU okay for Blenrep

GlaxoSmithKline has approval on both sides of the Atlantic for its multiple myeloma drug Blenrep, after getting the nod from the European Commission.

News

FDA approves GSK's Blenrep for advanced multiple myeloma

The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep, a first-in-class potential blockbuster that will be used in advanced disease.

News

CHMP gives nod to GSK’s BCMA drug Blenrep for myeloma

GlaxoSmithKline is closing in on EU approval for its first-in-class BCMA-targeting drug Blenrep, after getting a green light from the EMA’s human medicines committee.

BCMA Targeted Therapies Summit

GSK moves further ahead in BCMA with EU okay for Blenrep

FDA approves GSK's Blenrep for advanced multiple myeloma

CHMP gives nod to GSK’s BCMA drug Blenrep for myeloma

NHS to offer Wegovy to a million more people in England

Using AI-driven synthetic personas to take your insights fur...

Blenrep

Editor's Picks